Viking Therapeutics, Inc. 's share was trading at $32.07 as ... If VKTX captures even a modest share, its valuation could soar: base case implies $180/share on $5B in revenue, with a bull case of $360 ...

Viking Therapeutics (NASDAQ: VKTX) just gave shareholders a few more reasons to be excited for the future. With its shares soaring by a stunning 34% on July 25 thanks to second-quarter earnings ...

On Dec 18, 2024, Viking announced 10 new ocean itineraries for 2026 and 2027 that are available for booking. The cruises range from 8 to 22 days on its small ocean ships which do not allow ...

Ulz is unquestionably a Viking bull, as his recommendation on the stock is overweight (read: buy) at a relatively high $105 per-share price target -- 67% above the stock's latest closing price.